ShockWave Medical (NASDAQ:SWAV)

I have heard mention a number of time that the potential market out there is 6 Billion Dollars for this cardiac catheter.

I can see this product in every cath lab in the country being used on a regular basis for difficult coronary lesions. So far I have not seen any red flags in the medical literature.

Thinking out loud, I wanted to do the math for potential growth of the company. Please correct my math if I am wrong. I'm a doctor, not a mathematician.

Current sales estimate are about 195 million for 2021.
Market Potential 6,000,000,000.
If everything goes well there is the potential for 30X growth in this company.

On top of this amazing growth potential, there is a huge difference between investing in SWAV and investing in strip mining rare earth minerals, or cryptocurrency. SWAV is a product that helps physicians treat Cardiac Disease, the biggest killer of humans.

Heart Disease in the United States (Source the CDC)
Heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States.
One person dies every 36 seconds in the United States from cardiovascular disease.
About 655,000 Americans die from heart disease each year—that’s 1 in every 4 deaths.
Heart disease costs the United States about $219 billion each year from 2014 to 2015. This includes the cost of health care services, medicines, and lost productivity due to death.

Shockwave $SWAV Intravascular Lithotripsy approved for use by the FDA on route to become new standard of care in cardiac indications